BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35366177)

  • 1. Detection and characterization of mutations in genes related to isoniazid resistance in Mycobacterium tuberculosis clinical isolates from Iran.
    Bakhtiyariniya P; Khosravi AD; Hashemzadeh M; Savari M
    Mol Biol Rep; 2022 Jul; 49(7):6135-6143. PubMed ID: 35366177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characterization of the katG, inhA, ahpC, kasA, and oxyR gene mutations in isoniazid-resistant and susceptible strain of Mycobacterium tuberculosis by automated DNA sequencing].
    Chen X; Ma Y; Jin Q; Jiang GL; Li CY; Wang Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Apr; 28(4):250-3. PubMed ID: 15854436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of the coexistence of non-codon 315 katG, inhA, and oxyR-ahpC intergenic gene mutations among isoniazid-resistant and multidrug-resistant isolates of Mycobacterium tuberculosis: a report of novel mutations.
    Norouzi F; Moghim S; Farzaneh S; Fazeli H; Salehi M; Nasr Esfahani B
    Pathog Glob Health; 2022 Feb; 116(1):22-29. PubMed ID: 34086544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Jagielski T; Bakuła Z; Roeske K; Kamiński M; Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J
    J Antimicrob Chemother; 2014 Sep; 69(9):2369-75. PubMed ID: 24855126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of combined gene mutations in inhA and ahpC genes on high levels of isoniazid resistance amongst katG non-315 in multidrug-resistant tuberculosis isolates from China.
    Liu L; Jiang F; Chen L; Zhao B; Dong J; Sun L; Zhu Y; Liu B; Zhou Y; Yang J; Zhao Y; Jin Q; Zhang X
    Emerg Microbes Infect; 2018 Nov; 7(1):183. PubMed ID: 30446638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil.
    Cardoso RF; Cooksey RC; Morlock GP; Barco P; Cecon L; Forestiero F; Leite CQ; Sato DN; Shikama Mde L; Mamizuka EM; Hirata RD; Hirata MH
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3373-81. PubMed ID: 15328099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities.
    Sreevatsan S; Pan X; Zhang Y; Deretic V; Musser JM
    Antimicrob Agents Chemother; 1997 Mar; 41(3):600-6. PubMed ID: 9056000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of novel mutations associated with independent resistance and cross-resistance to isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates.
    Islam MM; Tan Y; Hameed HMA; Liu Z; Chhotaray C; Liu Y; Lu Z; Cai X; Tang Y; Gao Y; Surineni G; Li X; Tan S; Guo L; Cai X; Yew WW; Liu J; Zhong N; Zhang T
    Clin Microbiol Infect; 2019 Aug; 25(8):1041.e1-1041.e7. PubMed ID: 30583053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America.
    Dalla Costa ER; Ribeiro MO; Silva MS; Arnold LS; Rostirolla DC; Cafrune PI; Espinoza RC; Palaci M; Telles MA; Ritacco V; Suffys PN; Lopes ML; Campelo CL; Miranda SS; Kremer K; da Silva PE; Fonseca Lde S; Ho JL; Kritski AL; Rossetti ML
    BMC Microbiol; 2009 Feb; 9():39. PubMed ID: 19228426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA.
    Guo H; Seet Q; Denkin S; Parsons L; Zhang Y
    J Med Microbiol; 2006 Nov; 55(Pt 11):1527-1531. PubMed ID: 17030912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan.
    Tseng ST; Tai CH; Li CR; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2015 Jun; 48(3):249-55. PubMed ID: 24184004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China.
    Zhang M; Yue J; Yang YP; Zhang HM; Lei JQ; Jin RL; Zhang XL; Wang HH
    J Clin Microbiol; 2005 Nov; 43(11):5477-82. PubMed ID: 16272473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China.
    Li G; Zhang J; Jiang Y; Zhao LL; Liu H; Li M; Zhao X; Wan K
    J Glob Antimicrob Resist; 2020 Mar; 20():275-281. PubMed ID: 31425771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.
    Hazbón MH; Brimacombe M; Bobadilla del Valle M; Cavatore M; Guerrero MI; Varma-Basil M; Billman-Jacobe H; Lavender C; Fyfe J; García-García L; León CI; Bose M; Chaves F; Murray M; Eisenach KD; Sifuentes-Osornio J; Cave MD; Ponce de León A; Alland D
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2640-9. PubMed ID: 16870753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
    Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
    Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
    BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Review of Mutations Associated with Isoniazid Resistance Points to Continuing Evolution and Subsequent Evasion of Molecular Detection, and Potential for Emergence of Multidrug Resistance in Clinical Strains of Mycobacterium tuberculosis.
    Valafar SJ
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa.
    Kiepiela P; Bishop KS; Smith AN; Roux L; York DF
    Tuber Lung Dis; 2000; 80(1):47-56. PubMed ID: 10897383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis.
    Ramaswamy SV; Reich R; Dou SJ; Jasperse L; Pan X; Wanger A; Quitugua T; Graviss EA
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1241-50. PubMed ID: 12654653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated liquid culture system misses isoniazid heteroresistance in Mycobacterium tuberculosis isolates with mutations in the promoter region of the inhA gene.
    Zhang Z; Lu J; Wang Y; Pang Y; Zhao Y
    Eur J Clin Microbiol Infect Dis; 2015 Mar; 34(3):555-60. PubMed ID: 25344830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.